pI: 8.611 |
Length (AA): 1509 |
MW (Da): 162668 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 6 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
327 | 1119 | 3ces (A) | 4 | 516 | 47.00 | 0 | 1 | 0.219714 | 1.96 |
329 | 1076 | 2zxi (A) | 7 | 562 | 36.00 | 0 | 1 | 0.414993 | 0.96 |
630 | 1233 | 3cp8 (A) | 154 | 617 | 31.00 | 0 | 1 | 0.263765 | 1.92 |
656 | 1168 | 3ces (A) | 184 | 550 | 38.00 | 0 | 1 | 0.18046 | 1.75 |
658 | 1008 | 3ces (A) | 186 | 522 | 36.00 | 0 | 1 | 0.437904 | 0.7 |
1185 | 1265 | 1oqy (A) | 101 | 178 | 36.00 | 0.86 | 0.05 | 0.320878 | 0.58 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | VEG Tachyzoite, ME49 Tachyzoite, ME49 Bradyzoite. | Gregory Sibley/Greg |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | ME49 merozoite. | Hehl AB |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 0-20% percentile | ME49 Oocyst. | Fritz HM |
Hehl AB | Asexual expansion of Toxoplasma gondii merozoites is distinct from tachyzoites and entails expression of non-overlapping gene families to attach, invade, and replicate within feline enterocytes. |
Gregory | ToxoDB |
Fritz HM | Transcriptomic analysis of toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts. |
Sibley/Greg | ToxoDB |
Ortholog group members (OG5_127775)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G13440 | glucose-inhibited division family A protein |
Babesia bovis | BBOV_III003040 | glucose inhibited division protein A family protein |
Brugia malayi | Bm1_42115 | Hypothetical 71.7 kDa protein F52H3.2 in chromosome II, putative |
Candida albicans | CaO19.5050 | similar to evolutionarily conserved MTO/gidA protein which is involved in the hypermodification of the wobble position of some t |
Candida albicans | CaO19.12517 | similar to evolutionarily conserved MTO/gidA protein which is involved in the hypermodification of the wobble position of some t |
Caenorhabditis elegans | CELE_F52H3.2 | Protein F52H3.2 |
Chlamydia trachomatis | CT_498 | tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG |
Dictyostelium discoideum | DDB_G0289183 | hypothetical protein |
Drosophila melanogaster | Dmel_CG4610 | CG4610 gene product from transcript CG4610-RA |
Escherichia coli | b3741 | 5-methylaminomethyl-2-thiouridine modification at tRNA U34 |
Homo sapiens | ENSG00000135297 | mitochondrial tRNA translation optimization 1 |
Loa Loa (eye worm) | LOAG_12795 | glucose inhibited division protein A |
Loa Loa (eye worm) | LOAG_07910 | glucose inhibited division protein A |
Mus musculus | ENSMUSG00000032342 | mitochondrial translation optimization 1 homolog (S. cerevisiae) |
Neospora caninum | NCLIV_017330 | tRNA uridine 5-carboxymethylaminomethyl modification enzyme GidA, related |
Oryza sativa | 4325242 | Os01g0960300 |
Onchocerca volvulus | OVOC10804 |
|
Plasmodium berghei | PBANKA_1457300 | glucose inhibited division protein a homologue, putative |
Plasmodium falciparum | PF3D7_1244000 | glucose inhibited division protein a homologue, putative |
Plasmodium knowlesi | PKNH_1463300 | glucose inhibited division protein a homologue, putative |
Plasmodium yoelii | PY01214 | Glucose inhibited division protein A |
Saccharomyces cerevisiae | YGL236C | Mto1p |
Schmidtea mediterranea | mk4.064901.00 | |
Toxoplasma gondii | TGME49_242010 | glucose inhibited division protein A subfamily protein |
Treponema pallidum | TP0044 | tRNA uridine 5-carboxymethylaminomethyl modification enzyme GidA |
Theileria parva | TP04_0141 | glucose inhibited division protein A, putative |
Wolbachia endosymbiont of Brugia malayi | Wbm0611 | tRNA uridine 5-carboxymethylaminomethyl modification enzyme GidA |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
b3741 | Escherichia coli | non-essential | goodall |
CELE_F52H3.2 | Caenorhabditis elegans | embryonic arrest | wormbase |
CELE_F52H3.2 | Caenorhabditis elegans | larval arrest | wormbase |
YGL236C | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_1457300 | Plasmodium berghei | Essential | plasmo |
TGME49_242010 this record | Toxoplasma gondii | Probably essential | sidik |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.